Community-acquired bacterial coinfections and COVID-19

EditorialCommunity-Acquired Bacterial Co-infections and COVID-19Michael John Patton, Amit Gaggar, Matthew Might, Nathaniel Erdmann, Carlos J. Orihuela, and Kevin S. HarrodMichael John Patton1United States, Amit Gaggar* Corresponding Author; email: [email protected]2Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, United States*, Matthew Might3Director, Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, AL, United States, Nathaniel Erdmann4Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, United States, Carlos J. Orihuela5Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, United States, and Kevin S. Harrod6Department of Anesthesiology, University of Alabama at Birmingham, Birmingham, AL, United StatesPublished Online:17 Aug 2023https://doi.org/10.1152/physrev.00010.2023MoreSectionsPDF (13 MB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInWeChat Previous Back to Top Next Download PDF FiguresReferencesRelatedInformation More from this issue > Articles in PressPublished 8/17/23 5:06 AM Spotlight Cover View larger Microbial synergy and pulmonary immune response in influenza and SARS-CoV-2 community-acquired bacterial co-infections. Crossmark Copyright & PermissionsCopyright © 2023, Physiological Reviewshttps://doi.org/10.1152/physrev.00010.2023PubMed37589392History Received 24 February 2023 Accepted 5 August 2023 Published online 17 August 2023 KeywordsCommunity-Acquired Bacterial Co-infectionCOVID-19 and InfluenzaMechanisms of Microbial SynergyCritical Care Outcome ModelingRisk Factor Analysis Metrics